|
|
||||||||
Ann Thorac Surg 1995;60:1312-1316
© 1995 The Society of Thoracic Surgeons
Department of Cardiovascular Diseases, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Accepted for publication June 17, 1995.
* Address reprint requests to Dr Duran, The International Heart Institute of Montana Foundation, 554 W Broadway, Missoula, MT 59802.
Background.: Because of the difficulty of permanent anticoagulation in our young population, Smeloff-Cutter ball valves have been used since 1986 at our institution of aortic valve replacement in selected patients without permanent anticoagulation therapy.
Methods.: The availability of a satisfactory follow-up system since July 1988 suggested a study of all 47 patients operated on since then and followed for a mean of 43.2 months (range, 16 to 78 months). Mean age was 26.3 years, 98% were in sinus rhythm, and 16 patients (34%) had concomitant mitral repair.
Results.: There were no hospital deaths. Three patients were lost to follow-up at a mean of 27 months. Four late deaths occurred (8.5%), two of them sudden, with actuarial survival at 6 years of 91% ± 4.3%. There were a total of five embolic events (2.9%/patient-year). For isolated aortic valve replacement only, with antiaggregant therapy (n = 29), the incidence was 0.9%/patient-year. For all patients receiving antiaggregant agents (n = 43), it was 3.02%/patient-year. There were no known cases of valve thrombosis. Reoperation was required in 5 patients.
Conclusions.: Aortic valve replacement with the Smelloff-Cutter ball valve might be a valid alternative for young patients unable to maintain regular anticoagulation.
This article has been cited by other articles:
![]() |
K. Kanki, N. Takagi, K. Tachibana, T. Mishina, and T. Higami Smeloff-Cutter aortic valve endocarditis 31 years after implantation Asian Cardiovasc Thorac Ann, April 1, 2011; 19(2): 163 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Si and A. Zapolanski A 37-Year-Old Smeloff-Cutter Aortic Valve Ann. Thorac. Surg., February 1, 2009; 87(2): 628 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 593S - 629S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suezawa, T. Morimoto, T. Jinno, and M. Tago Forty-Year Survival With Smeloff-Cutter and Starr-Edwards Prostheses Ann. Thorac. Surg., March 1, 2008; 85(3): e14 - e16. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 457S - 482S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Milo, E. Rambod, C. Gutfinger, and M. Gharib Mitral mechanical heart valves: in vitro studies of their closure, vortex and microbubble formation with possible medical implications Eur J Cardiothorac Surg, September 1, 2003; 24(3): 364 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Naito, M. Nakajima, H. Inoue, N. Hibino, E. Mizutani, and K. Tsuchiya Unexpected durability of smeloff-cutter aortic ball valve prosthesis Ann. Thorac. Surg., May 1, 2003; 75(5): 1633 - 1635. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |